Carregant...
Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy
Sorafenib is an oral multikinase inhibitor with anti-proliferative and anti-angiogenic effects and is used worldwide for the treatment of advanced or metastatic hepatocellular carcinoma (HCC). While the significant survival benefit of sorafenib in patients with advanced HCC was demonstrated, various...
Guardat en:
| Publicat a: | Surg Case Rep |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4713402/ https://ncbi.nlm.nih.gov/pubmed/26943680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-016-0131-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|